1. Atrial Fibrillation in Africa-An Underreported and Unrecognized Risk Factor for Stroke: A Systematic Review

   Jacobs, M. S., van Hulst, M., Adeoye, A. M., Tieleman, R. G., Postma, M. J. & Owolabi, M. O., Sep-2019, In : Global heart. 14, 3, p. 269-279

   Research output: Contribution to journal › Review article › Academic › peer-review

2. To Bridge or Not to Bridge: Modelling Periprocedural Anticoagulation Management

   van der Pol, S., Jacobs, M., Meijer, K., Piersma-Wichers, M. G., Tieleman, RG., Postma, M. & van Hulst, M., 3-Aug-2018, p. E417. 1 p.

   Research output: Contribution to conference › Poster › Academic

3. Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!

   Jacobs, M. S. & Tieleman, R. G., Jun-2018, In : Netherlands Heart Hournal. 26, 6, p. 334-340 7 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

4. Letter responding to Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Societad Latinoamericana de Estimulation Cardiaca y Electrofisiologia (SOLAECE)

   Jacobs, M. S., van Hulst, M. & Tieleman, R. G., 1-May-2018, In : Europace. 20, 5, p. 893-893 1 p.

   Research output: Contribution to journal › Letter › Academic › peer-review

5. Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands

   Jacobs, M. S., Schouten, J. F., de Boer, P. T., Hoffmann, M., Levin, L-Å. & Postma, M. J., 2018, In : Current Medical Research and Opinion. 34, 10, p. 1839-1847 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (10) »